Pearl River Capital’s Thermo Fisher Scientific TMO Stock Holding History

Pearl River Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,660	Closed	-$965K	–	626
2024 Q1	$965K	Buy	+1,660	New	+$931K	0.15%	198
2023 Q4	–	Sell	-478	Closed	-$242K	–	625
2023 Q3	$242K	Buy	+478	New	+$255K	0.04%	447
2022 Q1	–	Sell	-3,398	Closed	-$2.27M	–	556
2021 Q4	$2.27M	Buy	+3,398	New	+$2.12M	0.61%	36
2021 Q2	–	Sell	-551	Closed	-$251K	–	574
2021 Q1	$251K	Sell	551 -2,316	-81%	-$1.11M	0.08%	327
2020 Q4	$1.33M	Buy	2,867 +2,317	+421%	+$1.09M	0.48%	58
2020 Q3	$243K	Buy	+550	New	+$227K	0.1%	304
2020 Q2	–	Sell	-300	Closed	-$85K	–	561
2020 Q1	$85K	Sell	300 -3,276	-92%	-$1.03M	0.16%	181
2019 Q4	$1.16M	Buy	+3,576	New	+$1.08M	0.43%	38
2019 Q3	–	Sell	-229	Closed	-$67K	–	530
2019 Q2	$67K	Buy	+229	New	+$63.1K	0.43%	113
2019 Q1	–	Sell	-564	Closed	-$126K	–	759
2018 Q4	$126K	Buy	+564	New	+$132K	0.58%	21

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pearl River Capital's TMO Position: Q2 2024 in Review

Pearl River Capital sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 1,660 shares — an estimated $965K sold.

Pearl River Capital first reported a position in TMO in Q4 2018 and held it in 10 quarters. The position peaked at $2.27M in Q4 2021. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

Pearl River Capital reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
Pearl River Capital sold 1,660 Thermo Fisher Scientific shares in Q2 2024, an estimated $965K.
Pearl River Capital first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 10 quarters.
Pearl River Capital's Thermo Fisher Scientific position peaked at $2.27M in Q4 2021.
2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Pearl River Capital's 13F filing for Q2 2024, filed 13 Aug 2024.